Shattuck Labs, Inc. (STTK) community

STTKNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30

$4.65−0.16 (-3.33%)

Close on Nov 13, 2026Market cap $466.69MP/E –Yield –

Community

Notes and questions about Shattuck Labs from other investors

No posts about STTK yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Shattuck Labs's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is STTK.

Compare: STTK vs IBIO · STTK vs YARW · STTK vs DNTH · STTK vs RNAC · STTK vs MCRB

Revenue growth-100.0% · median 115.0%

Company	Revenue	Growth
MCRB	$2.13M	+505.4%
IBIO	$1.08M	+115.0%
RNAC	$1.03M	–
YARW	$476.00K	-2.1%
STTK	$0	-100.0%
DNTH	–	–

Company

Next earnings (est.): Mar 4, 2027, before open
Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 40
Held by institutions: 83.5%
Auditor: KPMG LLP
SEC CIK: 1680367

Advertisement
300 × 250

See a number that looks wrong?